SEC Insider Transactions from Seth Kiernan.

Last updated: 2026-03-14 11:16 UTC | Total transactions: 9

Seth Kiernan has filed 9 insider transactions across 1 company since February 2023.

Most recent transaction: a option exercise of 14833 shares of LEXICON PHARMACEUTICALS, INC. ($LXRX) on February 28, 2023.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Feb. 28, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Seth Kiernan VP, Chief Commercial Officer M Common Stock 14833 $0.00 36,700.0000 0 67.83% 0.00%
Feb. 28, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Seth Kiernan VP, Chief Commercial Officer M Common Stock 5286 $0.00 41,986.0000 0 14.40% 0.00%
Feb. 28, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Seth Kiernan VP, Chief Commercial Officer M Common Stock 22963 $0.00 64,949.0000 0 54.69% 0.00%
Feb. 28, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Seth Kiernan VP, Chief Commercial Officer F Common Stock 11813 $2.17 53,136.0000 0 18.19% 0.00%
Feb. 28, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Seth Kiernan VP, Chief Commercial Officer M Restricted Stock Units 14833 $0.00 0.0000 0 100.00% 0.00%
Feb. 28, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Seth Kiernan VP, Chief Commercial Officer M Restricted Stock Units 5286 $0.00 5,287.0000 0 50.00% 0.00%
Feb. 28, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Seth Kiernan VP, Chief Commercial Officer M Restricted Stock Units 22963 $0.00 45,927.0000 0 33.33% 0.00%
Feb. 9, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Seth Kiernan VP, Chief Commercial Officer A Restricted Stock Units 93370 $0.00 93,370.0000 0 9999.99% 0.00%
Feb. 9, 2023 LEXICON PHARMACEUTICALS, INC. $LXRX Seth Kiernan VP, Chief Commercial Officer A Stock Option (Right to Buy) 280100 $0.00 280,100.0000 0 9999.99% 0.00%